Klin Padiatr 2019; 231(03): 168
DOI: 10.1055/s-0039-1687171
DOI: 10.1055/s-0039-1687171
Abstracts
NAMPT-mediated LMO2 deacetylation is indispensable for hematopoiesis and T-ALL leukemogenesis
T Morishima
1
Department of Oncology, Hematology, Immunology, Rheumatology and Pulmonology, University
Hospital Tübingen, Germany
,
AC Krahl
1
Department of Oncology, Hematology, Immunology, Rheumatology and Pulmonology, University
Hospital Tübingen, Germany
,
Y Xu
1
Department of Oncology, Hematology, Immunology, Rheumatology and Pulmonology, University
Hospital Tübingen, Germany
,
N Aghaallaei
1
Department of Oncology, Hematology, Immunology, Rheumatology and Pulmonology, University
Hospital Tübingen, Germany
,
M Nasri
1
Department of Oncology, Hematology, Immunology, Rheumatology and Pulmonology, University
Hospital Tübingen, Germany
,
B Findik
1
Department of Oncology, Hematology, Immunology, Rheumatology and Pulmonology, University
Hospital Tübingen, Germany
,
B Bajoghli
1
Department of Oncology, Hematology, Immunology, Rheumatology and Pulmonology, University
Hospital Tübingen, Germany
,
P Müller
2
Friedrich Miescher Laboratory of the Max Planck Society, Tübingen, Germany
,
K Welte
3
University Children's Hospital Tübingen, Germany
,
J Skokowa
1
Department of Oncology, Hematology, Immunology, Rheumatology and Pulmonology, University
Hospital Tübingen, Germany
› Author Affiliations
